• Enhanced Production of A40926 via Engineered N. gerenzanensi

  2026-04-30

  This study demonstrates a significant increase in A40926 yield by combining targeted gene manipulations with optimized fermentation media in Nonomuraea gerenzanensis. The findings provide a robust framework for scalable glycopeptide antibiotic production, relevant to both fundamental research and preclinical development.

• Distinct Gene Expression Drives Urethral Groove Formation in

  2026-04-30

  This study uncovers how differential expression of Shh, Fgf10, and Fgfr2 orchestrates the unique formation of the prepuce and urethral groove in guinea pigs versus mice. The findings refine our understanding of mammalian penile development and provide a molecular framework for comparative embryology and potential translational research.

• ECL Western Blotting Substrate: Protocol and QC for HRP Dete

  2026-04-29

  ECL Western Blotting Substrate (SKU K2187) addresses the need for sensitive, nonradioactive detection of HRP-conjugated proteins in chemiluminescent Western blot assays. It is best applied in molecular biology, cancer biology protein analysis, and signal transduction pathway research. This substrate should not be used for fluorescent or radioisotopic detection workflows.

• BicD and MAP7 Synergistically Activate Drosophila Kinesin-1

  2026-04-29

  This study uncovers how adaptor protein BicD and microtubule-associated protein MAP7 activate homodimeric Drosophila kinesin-1 through complementary mechanisms. The findings clarify the role of BicD in relieving kinesin auto-inhibition and demonstrate that MAP7 enhances microtubule engagement, with combined action yielding maximal motor activation—insights that advance understanding of intracellular transport regulation.

• Prostaglandin E2: Precision Modulation of Inflammation and R

  2026-04-28

  Explore the advanced roles of Prostaglandin E2 (PGE2) in inflammation research and tissue regeneration, with a unique focus on intervertebral disc degeneration (IVDD) and macrophage-mediated signaling. Discover how high-purity PGE2 products from APExBIO empower next-generation regenerative medicine studies.

• EDC.HCl: Technical Guide for Peptide and Bioconjugation Prot

  2026-04-28

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for reliable amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is optimized for in vitro biochemical protocols and should not be used in in vivo or clinical research due to the absence of supporting data.

• 3-Bromopyruvate and Cetuximab: Overcoming CRC Drug Resistanc

  2026-04-27

  This study demonstrates that co-treatment with 3-bromopyruvate and cetuximab can overcome resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The mechanistic insights into FOXO3a pathway modulation highlight new therapeutic strategies for drug-resistant CRC.

• BIIE 0246 in Translational Neurocardiac Research: Beyond Y2R

  2026-04-27

  Explore the advanced applications of BIIE 0246 as a potent neuropeptide Y Y2 receptor antagonist in dissecting neurocardiac and adipose-neural axis mechanisms. This article uniquely bridges synaptic, behavioral, and arrhythmogenic research, offering nuanced assay insights.

• CUDC-907: Technical Guidance for Dual PI3K and HDAC Inhibiti

  2026-04-26

  CUDC-907 enables in vitro researchers to simultaneously inhibit class I PI3K and select HDAC isoforms, facilitating the study of complex signaling pathways in established cancer cell models. This product is intended only for controlled laboratory experiments and should not be used in diagnostic or medical applications.

• CCCP: Mechanism, Benchmarks, and Limits in Mitochondrial Res

  2026-04-25

  CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is a gold-standard mitochondrial uncoupler used to study oxidative phosphorylation inhibition and mitochondrial dysfunction. Its precise disruption of the proton gradient underpins reproducible bioenergetics assays but is limited to in vitro systems. Proper understanding of CCCP’s properties and evidence-based protocols is essential for reliable mitochondrial research.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-04-24

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is not suitable for in vivo or clinical use due to the absence of supporting data, and is intended for in vitro biochemical protocols requiring controlled amide bond formation.

• MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliu

  2026-04-24

  Leverage MTT’s unmatched sensitivity for quantitative in vitro cell proliferation, viability, and metabolic activity measurements. Discover actionable experimental strategies, troubleshooting, and protocol enhancements—grounded in recent multidrug resistance and cancer research, and powered by APExBIO’s high-purity reagent.

• Foretinib (GSK1363089): Precision Assay Design for Oncology

  2026-04-23

  Explore the advanced use of Foretinib (GSK1363089) in designing precise, mechanism-driven cancer assays. This article delivers a unique synthesis of cutting-edge methodology and translational applicability, guiding researchers far beyond standard protocols.

• Dual-Action p38α MAPK Inhibitors Promote Dephosphorylation

  2026-04-23

  This study reveals that certain p38α MAPK inhibitors not only block kinase activity but also accelerate dephosphorylation by stabilizing conformations accessible to phosphatases. Structural and biochemical analyses uncover a novel mechanism with direct implications for the design of more potent and specific kinase inhibitors.

• Angiotensin II (A1042): Technical Guidance for Vascular Mode

  2026-04-22

  Angiotensin II (SKU A1042) enables controlled induction of vasoconstriction and vascular remodeling in research models of hypertension, cardiovascular adaptation, and abdominal aortic aneurysm. It is not intended for diagnostic or therapeutic use, and its experimental application should strictly follow validated protocols to avoid off-target or artifact effects.

16634 records 1/1109 page Next 12345 下5页 Last page